Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion-Reference-Cited by-同舟云学术

Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion

Published:2016-06-27 Issue:6 Volume:11 Page:e0158297
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bruder Costa Juliana,Dufeu-Duchesne Tania,Leroy Vincent,Bertucci Inga,Bouvier-Alias Magali,Pouget Noelle,Brevot-Lutton Ophelie,Bourliere Marc,Zoulim Fabien,Plumas Joel,Aspord Caroline,

Funder

EFS

ANRS (France Recherche Nord Sud Sida-hiv Hepatites)

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Update in the management of chronic hepatitis B;SR Tujios;Current opinion in gastroenterology,2013

2. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection;Journal of hepatology,2012

3. Randomised study comparing 48 and 96 weeks peginterferon alpha-2a therapy in genotype D HBeAg-negative chronic hepatitis B;P Lampertico;Gut,2013

4. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;GK Lau;The New England journal of medicine,2005

5. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function;AM Woltman;PloS one,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B;Gut;2024-07-20

2. Predictive value of Th17 and Treg cells at baseline for HBsAg loss in chronic hepatitis B patients with low HBsAg quantification treated with pegylated interferon and nucleos(t)ide analogue;Liver Research;2023-06

3. Tumor-associated fibrosis impairs the response to immunotherapy;Matrix Biology;2023-05

4. Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B;American Journal of Gastroenterology;2022-12-23

5. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy;Frontiers in Immunology;2022-11-21